Background: Silicone breast implants have been used for post-mastectomy breast reconstruction and cosmetic augmentation since the 1960s. Recent regulatory action has resulted in a few devices being suspended or cancelled from the Australian market.
Objective: The aim of this article is to summarise important clinical information on how best to assess women with breast implants, and recognise and manage adverse events related to these devices.